VIC Tech 2025 Mid-Year Update
VIC Tech achieved key milestones in H1 2025, including portfolio advancements, strategic partnerships, and talent development. We remain focused on FDA submissions, clinical trials, and scaling initiatives to drive...
VIC Tech Expands Strategic Advisory Board with Addition of MedTech Innovator and Gastroenterology Expert Virender “VK” Sharma, MD
VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Virender “VK” Sharma, MD, to its Strategic Advisory Board (SAB). A recognized...
Market Access for Medical Devices in Europe: England, France, Germany, Italy, and Spain
Introduction VIC Technology Venture Development is pleased to introduce the first installment in a new educational series on international market access for life science innovations. This white paper, developed by our...
Women Shaping Life Sciences: Laura Lyons on Purpose, Perseverance, and Patient-Centered Innovation
In an industry where advanced degrees and technical titles often take center stage, Laura Lyons brings something just as powerful to the table; lived experience, heart, and a relentless drive to make life better for...
Enhance Diagnostics Granted FDA Breakthrough Device Designation
Fayetteville, AR – July 8, 2025 – Enhance Diagnostics, a clinical-stage company focused on non-invasive diagnostic solutions, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...
Nob Hill Therapeutics Expands Strategic Advisory Board with Two Distinguished Leaders in Respiratory Drug Development and Pulmonary Medicine
Albuquerque, NM - Nob Hill Therapeutics (NHT) is pleased to announcethe addition of two prominent experts to its Strategic Advisory Board: Dr. Mark Parry-Billings, a seasoned biotech and pharmaceutical executive with...
VIC Fellows Spotlight: Dhananjay Tambe, PhD
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...
Cellia Science Awarded $2M NIH SBIR Phase II Grant for Real-Time Bone Marrow Adequacy Assessment
Cellia Science announced today it has been awarded a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National...
Five Years of Impact: The VIC Fellows Program and the Future of Life Science Innovation
Launched in 2019, the VIC Fellows Program was created to harness the talents of individuals from a wide variety of scientific, medical, and commercial backgrounds and immerse them in the dynamic world of life science...
Fostering Life Science Innovation: Part 2 – Inventing with the End in Mind
The first article in this series [blog.victech.com/fostering-life-science-innovation-part-1-an-ecosystem-roadmap] set the stage by defining the primary components, drivers and benefits of life science innovation...
